Exciting news!
After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
The chip enables the detection of 30 fungal pathogens of systemic mycoses at species or genus level with a single test. In addition to 6 Aspergillus and 13 Candida group species, Fusarium spp., Mucor spp. and others are also represented on the chip.
Learn more here: zytomed-systems.com, or contact your local sales representative directly to explore your testing options.
Further topics
Coming soon: AmoyDx® FGFR1-4 NGS Panel
Detection of mutations and fusions in the FGFR1, FGFR2, FGFR3 and FGFR4 genes
S3 guideline for prostate cancer was updated
In May 2024 the S3 guideline "Prostate Cancer" (version 7.0) was updated. For the first time it is recommended to sequence genes involved in homologous recombination repair (HRR), e. g. ATM, BRCA1/2, BRIP1, CDK12, CHEK2, FANCA, HDAC2 and PALB2, before initiating a systemic therapy for castration-resistant prostate cancer (mCRPC).
